6.
Yang J, Kong S, Ahn H, Lee H, Jeong S, Ha J
. Prognostic factors for reoperation of recurrent retroperitoneal sarcoma: The role of clinicopathological factors other than histologic grade. J Surg Oncol. 2014; 111(2):165-72.
DOI: 10.1002/jso.23783.
View
7.
Toulmonde M, Bonvalot S, Meeus P, Stoeckle E, Riou O, Isambert N
. Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Ann Oncol. 2014; 25(3):735-742.
PMC: 4433510.
DOI: 10.1093/annonc/mdt577.
View
8.
. Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol. 2016; 23(11):3531-3540.
PMC: 5557018.
DOI: 10.1245/s10434-016-5336-7.
View
9.
Bonvalot S, Gronchi A, Le Pechoux C, Swallow C, Strauss D, Meeus P
. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2020; 21(10):1366-1377.
DOI: 10.1016/S1470-2045(20)30446-0.
View
10.
Pasquali S, Pizzamiglio S, Touati N, Litiere S, Marreaud S, Kasper B
. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial. Eur J Cancer. 2019; 109:51-60.
DOI: 10.1016/j.ejca.2018.12.009.
View
11.
Reichardt P, Tilgner J, Hohenberger P, Dorken B
. Dose-intensive chemotherapy with ifosfamide, epirubicin, and filgrastim for adult patients with metastatic or locally advanced soft tissue sarcoma: a phase II study. J Clin Oncol. 1998; 16(4):1438-43.
DOI: 10.1200/JCO.1998.16.4.1438.
View
12.
Ikoma N, Torres K, Lin H, Ravi V, Roland C, Mann G
. Recurrence patterns of retroperitoneal leiomyosarcoma and impact of salvage surgery. J Surg Oncol. 2017; 116(3):313-319.
PMC: 5937256.
DOI: 10.1002/jso.24667.
View
13.
Ray-Coquard I, Montesco M, Coindre J, Dei Tos A, Lurkin A, Ranchere-Vince D
. Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions. Ann Oncol. 2012; 23(9):2442-2449.
PMC: 3425368.
DOI: 10.1093/annonc/mdr610.
View
14.
Matthyssens L, Creytens D, Ceelen W
. Retroperitoneal liposarcoma: current insights in diagnosis and treatment. Front Surg. 2015; 2:4.
PMC: 4322543.
DOI: 10.3389/fsurg.2015.00004.
View
15.
Issels R, Lindner L, Verweij J, Wust P, Reichardt P, Schem B
. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol. 2010; 11(6):561-70.
PMC: 3517819.
DOI: 10.1016/S1470-2045(10)70071-1.
View
16.
Gronchi A, Ferrari S, Quagliuolo V, Broto J, Lopez Pousa A, Grignani G
. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol. 2017; 18(6):812-822.
DOI: 10.1016/S1470-2045(17)30334-0.
View
17.
van Houdt W, Fiore M, Barretta F, Rutkowski P, Blay J, Lahat G
. Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG. Cancer. 2020; 126(22):4917-4925.
DOI: 10.1002/cncr.33139.
View
18.
Fairweather M, Gonzalez R, Strauss D, Raut C
. Current principles of surgery for retroperitoneal sarcomas. J Surg Oncol. 2018; 117(1):33-41.
DOI: 10.1002/jso.24919.
View
19.
Antman K, Crowley J, Balcerzak S, Rivkin S, Weiss G, Elias A
. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol. 1993; 11(7):1276-85.
DOI: 10.1200/JCO.1993.11.7.1276.
View
20.
Raut C, Callegaro D, Miceli R, Barretta F, Rutkowski P, Blay J
. Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG. Clin Cancer Res. 2019; 25(8):2664-2671.
DOI: 10.1158/1078-0432.CCR-18-2700.
View